HK1152651A1 - Stable pharmaceutical formulation with limited discoloration - Google Patents
Stable pharmaceutical formulation with limited discolorationInfo
- Publication number
- HK1152651A1 HK1152651A1 HK11106768.4A HK11106768A HK1152651A1 HK 1152651 A1 HK1152651 A1 HK 1152651A1 HK 11106768 A HK11106768 A HK 11106768A HK 1152651 A1 HK1152651 A1 HK 1152651A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical formulation
- stable pharmaceutical
- discoloration
- limited
- limited discoloration
- Prior art date
Links
- 238000002845 discoloration Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008235354 | 2008-09-12 | ||
PCT/JP2009/065700 WO2010029930A1 (ja) | 2008-09-12 | 2009-09-09 | 変色が抑制された安定な医薬製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1152651A1 true HK1152651A1 (en) | 2012-03-09 |
Family
ID=42005183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11106768.4A HK1152651A1 (en) | 2008-09-12 | 2011-07-04 | Stable pharmaceutical formulation with limited discoloration |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2335697B1 (pt) |
JP (1) | JP5498387B2 (pt) |
KR (1) | KR101623608B1 (pt) |
CN (1) | CN102137663B (pt) |
BR (1) | BRPI0918539A2 (pt) |
HK (1) | HK1152651A1 (pt) |
MX (1) | MX340436B (pt) |
TW (1) | TWI445527B (pt) |
WO (1) | WO2010029930A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011049093A1 (ja) * | 2009-10-20 | 2011-04-28 | 第一三共ヘルスケア | 変色及び臭いが抑制されたフィルムコーティング錠 |
JP2013049671A (ja) * | 2011-08-04 | 2013-03-14 | Fancl Corp | アスコルビン酸製剤 |
JP6245786B2 (ja) * | 2011-10-17 | 2017-12-13 | 大同化成工業株式会社 | 医薬用結合剤及び該結合剤を用いた製剤 |
CN103054861A (zh) * | 2012-12-29 | 2013-04-24 | 北京阜康仁生物制药科技有限公司 | 一种含氨甲环酸的复方固体制剂 |
EP3173101B1 (en) * | 2014-07-25 | 2020-10-21 | Mitsubishi Chemical Corporation | Polyvinyl alcohol particles, pharmaceutical binder using same, pharmaceutical tablet, sustained-release pharmaceutical tablet, and method for producing polyvinyl alcohol particles |
EP3616696A4 (en) | 2017-04-28 | 2021-01-27 | Astellas Pharma Inc. | PHARMACEUTICAL COMPOSITION CONTAINING ENZALUTAMIDE WHICH MAY BE ADMINISTERED ORALLY |
JP2019081757A (ja) * | 2017-10-31 | 2019-05-30 | 武田コンシューマーヘルスケア株式会社 | 固形製剤の製造方法 |
JP7500548B2 (ja) * | 2018-10-09 | 2024-06-17 | ディーエスエム アイピー アセッツ ビー.ブイ. | 局所用組成物 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04243825A (ja) | 1991-01-25 | 1992-08-31 | Ss Pharmaceut Co Ltd | 色素沈着症治療剤 |
JPH093348A (ja) * | 1995-06-20 | 1997-01-07 | Lion Corp | 色素の変色抑制方法及び色素配合組成物 |
WO2002017848A1 (en) | 2000-08-29 | 2002-03-07 | Nisshin Kasei Co., Ltd. | Hard capsule |
JP2004217655A (ja) | 2002-12-27 | 2004-08-05 | Dai Ichi Seiyaku Co Ltd | 美白用組成物 |
JP2004250376A (ja) * | 2003-02-20 | 2004-09-09 | Lion Corp | 医薬組成物用色素、医薬組成物用色素の製造方法、医薬組成物及び医薬組成物の変色・退色防止方法 |
WO2005019286A1 (ja) | 2003-08-20 | 2005-03-03 | Shionogi & Co., Ltd. | 新規コーティング組成物 |
JP2005068115A (ja) * | 2003-08-28 | 2005-03-17 | Pola Chem Ind Inc | 安定な皮膚外用剤 |
JP2005314403A (ja) * | 2004-03-31 | 2005-11-10 | Dai Ichi Seiyaku Co Ltd | 新規美白用組成物 |
JPWO2006003965A1 (ja) * | 2004-06-30 | 2008-04-17 | 第一三共ヘルスケア株式会社 | 美白組成物 |
JP5614826B2 (ja) | 2005-07-13 | 2014-10-29 | 塩野義製薬株式会社 | 退色を抑制した製剤 |
JP2007091670A (ja) | 2005-09-29 | 2007-04-12 | Shionogi & Co Ltd | 退色が抑制された着色カプセル |
JP2007197410A (ja) * | 2006-01-30 | 2007-08-09 | Lion Corp | フィルムコーティング錠 |
JP2008201711A (ja) * | 2007-02-20 | 2008-09-04 | Ss Pharmaceut Co Ltd | システイン臭が低減された固形製剤 |
WO2010016509A1 (ja) * | 2008-08-06 | 2010-02-11 | 第一三共ヘルスケア株式会社 | 安定なトラネキサム酸とアスコルビン酸含有医薬組成物 |
KR101640958B1 (ko) * | 2008-09-05 | 2016-07-19 | 다이이찌 산쿄 헬스케어 가부시키가이샤 | 유효 성분이 경계를 사이에 두고 존재하여 이루어지는 의약 고형 제제 |
-
2009
- 2009-09-09 KR KR1020117005701A patent/KR101623608B1/ko active IP Right Grant
- 2009-09-09 BR BRPI0918539A patent/BRPI0918539A2/pt not_active IP Right Cessation
- 2009-09-09 MX MX2011002364A patent/MX340436B/es active IP Right Grant
- 2009-09-09 WO PCT/JP2009/065700 patent/WO2010029930A1/ja active Application Filing
- 2009-09-09 EP EP09813076.8A patent/EP2335697B1/en active Active
- 2009-09-09 CN CN200980134232.3A patent/CN102137663B/zh active Active
- 2009-09-09 JP JP2010528727A patent/JP5498387B2/ja active Active
- 2009-09-11 TW TW098130635A patent/TWI445527B/zh active
-
2011
- 2011-07-04 HK HK11106768.4A patent/HK1152651A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010029930A1 (ja) | 2010-03-18 |
EP2335697A1 (en) | 2011-06-22 |
JPWO2010029930A1 (ja) | 2012-02-02 |
JP5498387B2 (ja) | 2014-05-21 |
MX2011002364A (es) | 2011-04-04 |
EP2335697B1 (en) | 2014-03-12 |
CN102137663B (zh) | 2016-09-28 |
MX340436B (es) | 2016-07-08 |
TW201016212A (en) | 2010-05-01 |
KR20110057151A (ko) | 2011-05-31 |
EP2335697A4 (en) | 2011-08-17 |
KR101623608B1 (ko) | 2016-05-23 |
CN102137663A (zh) | 2011-07-27 |
BRPI0918539A2 (pt) | 2015-12-08 |
TWI445527B (zh) | 2014-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1800043I1 (hu) | 514 számú gyógyszerkészítmény | |
IL271132A (en) | New preparation and dosage | |
ZA201004793B (en) | Capsule formulation | |
IL206288A0 (en) | Novel dosage and formulation | |
HK1169960A1 (en) | Pharmaceutical formulation | |
ZA201104348B (en) | Pharmaceutical preparation | |
HK1152651A1 (en) | Stable pharmaceutical formulation with limited discoloration | |
PL394605A1 (pl) | Trwała złożona kompozycja farmaceutyczna | |
GB0815972D0 (en) | Pharmaceutical preparation | |
EP2268278A4 (en) | PHARMACEUTICAL COMPOSITION | |
EP2306998A4 (en) | PHARMACEUTICAL FORMULATION | |
IL208788A (en) | Pharmacy-based formulation | |
GB0817969D0 (en) | Pharmaceutical composition | |
HK1182939A1 (en) | Stable pharmaceutical composition | |
GB0805292D0 (en) | Pharmaceutical formulation | |
GB0918912D0 (en) | Improved medicament formulation | |
GB0813031D0 (en) | Pharmaceutical formulations | |
GB0810217D0 (en) | Pharmaceutical formulations | |
AU2008903115A0 (en) | Pharmaceutical Formulation | |
GB0705030D0 (en) | Pharmaceutical formulation | |
GB0817566D0 (en) | Pharmaceutical composition |